Pfizer board recommends ₹75 dividend for FY26
Pfizer Limited reported a 10.4% rise in revenue to ₹2,520 crore for FY26 and recommended a final dividend of ₹75 per share. The 75th AGM is scheduled for July 28, 2026, via video conferencing, with the record date set for July 17, 2026.
*this image is generated using AI for illustrative purposes only.
Pfizer Limited has recommended a final dividend of ₹75 per equity share of ₹10 each for the financial year ended March 31, 2026. The company reported a 10.4% increase in revenue from operations to ₹2,520 crore, while profit after tax stood at ₹722.43 crore. The 75th Annual General Meeting is scheduled for July 28, 2026, through video conferencing.
The Board of Directors, at its meeting held on May 12, 2026, approved the dividend recommendation. The record date for determining shareholder eligibility is July 17, 2026. If approved at the AGM, the dividend will be paid on or after August 4, 2026.
Financial Highlights
| Metric | FY 2026 (₹ in crore) | FY 2025 (₹ in crore) |
|---|---|---|
| Revenue from operations | 2,519.65 | 2,281.35 |
| Net sales | 2,377.11 | 2,128.36 |
| Profit before tax | 975.67 | 1,016.09 |
| Profit after tax | 722.43 | 767.60 |
| EBITDA margin | 35.9% | N/A |
The remote e-voting period will commence on July 24, 2026, and end on July 27, 2026. The cut-off date for determining eligibility for voting is July 21, 2026. The company has appointed KFin Technologies Limited to facilitate the e-voting process.
AGM Agenda
The AGM will transact ordinary business, including the adoption of audited financial statements and the declaration of the final dividend. Special business includes the ratification of remuneration payable to M/s. Kishore Bhatia & Associates, Cost Accountants, for the financial year ending March 31, 2027. The remuneration is fixed at ₹11,00,000 plus applicable taxes and out-of-pocket expenses. The Board has also proposed the re-appointment of Mr. P. Rengan, Director liable to retire by rotation.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE182A01018/a70a18ac531143eb.pdf
Historical Stock Returns for Pfizer
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.08% | +6.58% | +3.02% | -2.88% | -16.54% | -17.28% |
What factors contributed to the decline in profit before tax despite the 10.4% revenue growth?
How does the company plan to sustain or improve its EBITDA margin in the upcoming fiscal year?
Will Pfizer Limited maintain its current dividend payout ratio given the slight dip in net profit?
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
